9271SPhosphoAkt Ser473 Antibody and 6 more items

Virginia Commonwealth University (VCU) has awarded a contract to Cell Signaling Technology for the procurement of research-grade antibodies, with an award date of June 29, 2026. The cumulative contract value is $2,162.40. The contract encompasses seven distinct antibody products, all of which are to be delivered to VCU Procurement in Richmond, Virginia. These products include phosphoAkt Ser473 Antibody ($311.10), Cleaved PARP Asp214 Antibody ($362.95), Cyclin D1 Antibody ($269.45), phosphoEGF Receptor Tyr1068 D7A5 Rabbit antibody ($393.55), E-Cadherin 24E10 Rabbit Monoclonal Antibody ($298.35), PAX5 D7H5X Rabbit Monoclonal Antibody ($167.45), and Vinculin E1E9V Rabbit Monoclonal Antibody ($359.55).

Cell Signaling Technology will supply one unit each of the aforementioned antibodies, which are commonly used in cellular and molecular biology research applications. The line items indicate single-unit purchases of specialized research reagents, each with individual unit pricing. As a research institution, VCU's utilization of these antibodies suggests applications in protein analysis, cellular signaling pathway research, and related biochemical investigations. No specific contract period of performance dates are provided in the available documentation.